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A qualitative study of women’s views on medical confidentiality
Abstract
Context: The need to reinvigorate medical confidentiality protections is recognised as an important objective
in building patient trust necessary for successful health outcomes. Little is known about patient understanding
and expectations from medical confidentiality.
Objective: To identify and describe patient views of medical confidentiality and to assess provisionally the
range of these views.
Design: Qualitative study using indepth, open ended face-to-face interviews.
Setting: Southeastern Pennsylvania and southern New Jersey, USA.
Participants: A total of 85 women interviewed at two clinical sites and three community/research centres.
Main outcome measures: Subjects’ understanding of medical confidentiality, beliefs about the handling of
confidential information and concerns influencing disclosure of information to doctors.
Results: The subjects defined medical confidentiality as the expectation that something done or said would be
kept "private" but differed on what information was confidential and the basis and methods for protecting
information. Some considered all medical information as confidential and thought confidentiality protections
functioned to limit its circulation to medical uses and reimbursement needs. Others defined only sensitive or
potentially stigmatising information as confidential. Many of these also defined medical confidentiality as a
strict limit prohibiting information release, although some noted that specific permission or urgent need could
override this limit.
Conclusions: Patients share a basic understanding of confidentiality as protection of information, but some
might have expectations that are likely not met by current practice nor anticipated by doctors. Doctors should
recognise that patients might have their own medical confidentiality models. They should address divergences
from current practice and provide support to those who face emotional or practical obstacles to self-
revelation.
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Context: The need to reinvigorate medical confidentiality protections is recognised as an important
objective in building patient trust necessary for successful health outcomes. Little is known about patient
understanding and expectations from medical confidentiality.
Objective: To identify and describe patient views of medical confidentiality and to assess provisionally the
range of these views.
Design: Qualitative study using indepth, open ended face-to-face interviews.
Setting: Southeastern Pennsylvania and southern New Jersey, USA.
Participants: A total of 85 women interviewed at two clinical sites and three community/research centres.
Main outcome measures: Subjects’ understanding of medical confidentiality, beliefs about the handling of
confidential information and concerns influencing disclosure of information to doctors.
Results: The subjects defined medical confidentiality as the expectation that something done or said would
be kept ‘‘private’’ but differed on what information was confidential and the basis and methods for
protecting information. Some considered all medical information as confidential and thought
confidentiality protections functioned to limit its circulation to medical uses and reimbursement needs.
Others defined only sensitive or potentially stigmatising information as confidential. Many of these also
defined medical confidentiality as a strict limit prohibiting information release, although some noted that
specific permission or urgent need could override this limit.
Conclusions: Patients share a basic understanding of confidentiality as protection of information, but some
might have expectations that are likely not met by current practice nor anticipated by doctors. Doctors
should recognise that patients might have their own medical confidentiality models. They should address
divergences from current practice and provide support to those who face emotional or practical obstacles
to self-revelation.
R
esearch conducted in several countries, including
England, Australia, Canada, and the USA demonstrates
the importance of medical confidentiality to patients.
Findings suggest, for example, that patients who believe that
their privacy will be respected are more likely to seek
treatment, discuss problems openly, and return for follow
up care.1–13 In recognition of the importance of medical
confidentiality to successful health outcomes, the US federal
government recently adopted rules under the Health
Insurance Portability and Accountability Act (HIPAA) to
include the first comprehensive protection for the privacy of
health information in the USA.14
The primary purpose of the HIPAA privacy rule has been to
direct the creation of a system of rules, practices, and
oversight to protect medical information. Patient under-
standing of confidentiality is addressed in the rule’s require-
ment that healthcare providers explain to patients the
conditions under which their information can be used and
released to third parties.14 The rule also stipulates that this
information be provided in ‘‘plain language’’.15 However there
are reasons to suggest that additional effort might be
required to communicate effectively with patients about
medical confidentiality.
Firstly, research has shown that some lay definitions of
terms such as ‘‘private’’ and ‘‘confidential’’ differ from
professional and legal definitions that emphasise release of
information.16–20 Secondly, the technique on which the
HIPAA privacy rule relies for patient education differs little
from past methods used to inform patients about confidenti-
ality policies: the standardised form. Research has shown
that these forms are ineffective as ways to explain to patients
the release of information policies that HIPAA has replaced.21–23
Recent anecdotal reports describe patients who do not read
the new HIPAA forms or are confused by them, which
suggests that these forms are no more successful than their
predecessors.24–28 The shortcomings of standardised forms to
explain confidentiality policies might undercut one of the
putative goals of medical confidentiality protections: to
strengthen patient trust. This could be the case either if
patients do not understand the confidentiality rules in place
or if the rules do not effectively address confidentiality as
they understand it. Patient trust would seem to rely not only
on how information is actually handled but also on what
patients believe and understand about how it is
handled.23 29 30
The immediate consequence of the HIPAA privacy rule in
the USA has been to direct much needed attention to
patients’ medical confidentiality concerns, set aside too long.
To take advantage of this increased awareness, it is also
necessary to take fuller account of how patients understand
medical confidentiality and what they expect from it.
Currently little is known about patient understanding of
medical confidentiality. Recently, more studies reporting on
patients’ attitudes about confidential information disclosure
have begun to appear,31 32 yet it is still the case that less than
2% of the nearly 6000 articles that MEDLINE indexes to
medical confidentiality report on patient views.33 Most of
those that do address these examine vulnerable populations,
including adolescents, mental health patients, and human
immunodeficiency virus (HIV) positive patients. These
studies show that a small but notable minority of patients
misunderstand important features of medical confidentiality
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and that some possibly misunderstand the phrase
itself.16 17 19 20 34 35 Furthermore, based on their lay under-
standings of medical confidentiality, patients develop their
own strategies to balance a need for medical care against
threats posed by disclosure. Research has shown, for
example, that patients will withhold information or delay
care rather than reveal certain health information.1 35 36
It is not clear what reassurances or explanations would be
necessary to convince people to forgo these strategies.
Complete privacy of information is rarely an option because
continuity of medical care requires information sharing and,
in the USA, because of requirements for insurance reimbur-
sement. But failure to discuss confidentiality in terms that
patients understand could exacerbate patient mistrust and
strengthen the perceived need to conceal information or
avoid treatment. To initiate collection of data about patient
understanding of medical confidentiality, we designed an
exploratory study to describe patient views and to assess how
these views might differ.
METHODS
This study utilised indepth interviews with adult women. An
interview guide was developed and piloted, addressing
subjects’ understanding and experiences regarding medical
confidentiality.
Participants
We recruited women in southeastern Pennsylvania and
central New Jersey through two primary care practices
associated with large hospitals and through advertisements
in three local newspapers. We chose the clinics and news-
papers specifically to increase the chances of attracting
volunteers from diverse socioeconomic backgrounds and
age groups. Women over the age of 18 years were eligible
to participate and each was paid US$25.
Interview
We focused on women for this preliminary study because
women on average have more overall numbers of interactions
with healthcare providers due to the burden of reproductive
health issues and because women are more likely to be
responsible for seeking health care for members of their
family.37–39 It is important, then, to understand women’s
beliefs about medical confidentiality as they negotiate health
care for themselves and others. Furthermore, because there
are relatively few articles that enquire directly into patient
views limiting the research to women helped to focus the
enquiry and lay the groundwork for future research.
The subjects were interviewed in a private room in a
research or community centre close to their residence or in
the clinic where they were recruited. The same interview
guide was used for all subjects, although minor modifications
were made over the course of the study; older women were
asked an additional set of questions about menopause. The
interviews were conducted primarily by GJ, at the time a
postdoctoral fellow in bioethics, and secondarily by PS.
All interviews were audiotaped except two in which the
interviewees declined taping. These interviews were docu-
mented with handwritten notes. The interviews lasted
between 35 and 90 minutes. The institutional review boards
of the University of Pennsylvania and the hospitals that
housed the two clinics where we recruited subjects approved
this research. All subjects participated in approved informed
consent procedures.
The interview guide was piloted extensively in several
healthcare settings and revised several times until we
determined that its questions were comprehensible to the
population we were sampling. Pilot interviews indicated that
some women thought that confidentiality protections existed
to handle exceptional circumstances whereas others consid-
ered them standard practice. The final interview guide was a
semistructured tool that included both closed and open
ended questions. The questions were structured to explore
the possible differences in patient beliefs about whether
confidentiality practices were standard or routine and
possible variation in interpretation of the term ‘‘confidenti-
ality’’ reported in the literature.
The interview began with the interviewer asking the
subject a general question, such as to explain how she chose
a particular clinic for her health care. The interviewer then
asked the subject to reflect on a recent routine healthcare
visit, what information might have been collected during it,
and what happened to the information after the visit. These
questions were intended to elicit the woman’s basic under-
standing of the collection, storage, and use of personal
medical information. To determine whether subjects thought
that all medical information was handled roughly the same
or whether a range of procedures existed, these initial
questions were followed by similar questions enquiring about
medical information that was described specifically as
confidential.
Questions about confidential medical information began
by asking the subject to explain the meaning of confidenti-
ality: ‘‘If your doctor or nurse tells you that they’ll keep
something confidential, what does that mean to you?’’.
Additional questions elicited features that the interviewees
might associate with the treatment of confidential informa-
tion, such as specific rules governing its storage and
circulation, and whether the subject experienced difficulty
disclosing certain kinds of information.
Multilevel consensus coding
The tapes were transcribed verbatim and were entered into
QSR NUD*IST V.4, a qualitative data analysis software
program (Sage Publications Software, 1997; Thousand
Oaks, CA). We developed a preliminary coding scheme based
on results from pilot interviews and the literature. It was
tested on early interviews and revised until it efficiently and
adequately captured desired relevant information. The coding
scheme had three levels that were applied sequentially and
that required three separate readings of each interview.
First level coding generated standard, comparable answers to
close ended questions. Second level coding examined
anecdotes and examples from the respondents’ personal
experiences with confidentiality procedures or expectations
in medical settings. Its goal was to collect and characterise
the central experiences, ideas, and issues that informed each
interviewee’s perceptions of confidentiality. Categories for
these data were proposed based on insights garnered during
first level coding. These categories were finalised through
multiple trial codings of a subset of 20 randomly selected
interviews.
Coders were trained intensively by coding several inter-
views that had been analysed during the development of the
coding scheme. Two coders read and coded each level of each
interview individually, then met together to compare their
individual coding choices and to come to agreement on one
set of codes for the interview. Disagreements were discussed.
Those that could not be resolved were referred to a weekly
consensus meeting, which all pairs of coders attended. Data
that could not be coded in the consensus meeting were
omitted from the analysis.
RESULTS
Between 1998 and 2000 we conducted 85 interviews with a
diverse group of participants (average age 35 years; range 18–
75) (table 1). This sample was younger than the general
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population in the region sampled and reflected a higher level
of education.40 41
Collecting and using medical information
The subjects were prompted first to reflect on the interactions
that occurred during a routine visit to their doctor and then
asked about what part of the interactions would be
documented and what would happen to this information
following the consultation. Responses about these topics
were similar across subjects. Some emphasised what the
doctor would document such as, ‘‘Why I came in’’, whereas
others highlighted the purpose of documentation, as in, ‘‘it
may be data that they need to go back to if anything comes
up down the line’’.
When asked what happens to their medical record or
information after the visit, most answered that it would be
processed by a secretary or nurse and stored in a file cabinet
or in a computer database. Most added that the information
could be sent or given to someone else, although they
disagreed about exactly why or how this might happen. Two
main distinctions in these examples were whether sharing
information was routine and acceptable or whether it was
exceptional and, at least at times, inappropriate. Some
thought sharing was routine—but only within the clinical
setting where the information was first collected—implying,
and sometimes stating, that to use or send information
beyond this setting was wrong.
I don’t think it’s sent anywhere. … When they have to
agree with one another, I think they show another doctor
what’s in here. Like in other words if I need a medication
they’ll show the other doctor or have another doctor come
in and check me. I think they do that, like between their
selves. But as far as it going any further, I don’t think so. I
really don’t think so, you know. (A135)
Although some respondents recognised the need for
medical information to circulate for medical or reimburse-
ment needs, more than a quarter of subjects (n=23)
spontaneously declared that until the occasion of the inter-
view, they had not fully understood the implications of this
for their own medical information. An older woman who
worked as a secretary in a firm that handled pre-employment
physicals and employee drug testing, stated:
Originally until I came here right now I wasn’t thinking that
way. I was like, I talk to my doctor and my file gets put
away and that’s it. But it really isn’t so confidential if you
think about it. (D254)
Medical confidentiali ty definitions
Enquiry into the handling of medical information designated
confidential and into lay definitions of confidentiality began
with the question, ‘‘If your doctor or nurse tells you that
they’ll keep something confidential, what does that mean to
you?’’. Nearly all women described confidentiality as an
expectation that something done or said would be kept
‘‘private’’, but their answers differed concerning the basis,
limits, and significance of this protection.
The largest group (n=50) of respondents emphasised the
personal relationship in which information is exchanged,
whether with a doctor, other professional, or a friend, and
voiced the belief that confidential information was shared
between only teller and listener.
It means that they won’t tell anybody else the information.
It’s only information that they know. I mean, they know
that that information belongs to you, but they won’t tell
anybody else. (B101)
These responses also sometimes emphasised the sensitive
or secret nature of the information that women considered
subject to confidentiality protections.
It means when you tell somebody something it’s between
just you and them. And you tell them in, you know, in other
words, it’s like a secret you can tell her, confide in them.
You know, like if I tell my girlfriend, my friend, I can tell her
anything and she’ll hold it to herself. It don’t go no further,
you know. And whatever she tells me, it don’t go no
further. So, I mean, when you come to a doctor that’s what
it’s supposed to be. It’s supposed to be between patient
and doctor. Whatever you tell your doctor is supposed to
be just between you and the doctor. So I guess it’s what
they do. You know, I hope they do that, you know. (A135)
A subset of this group (n=14) did stipulate that with
express permission a doctor could reveal confidential
information to another healthcare practitioner.
Another group of common responses (n=27) charac-
terised confidentiality as a set of bureaucratic procedures that
allow information to be used for defined and discreet
purposes, such as continuity of medical care, while protecting
it from other uses. The information protected might be
thought of as secret, but responses highlight the use of
information rather than its concealment.
R: [Confidentiality means] that I would have an under-
standing with my healthcare professional that what I said
to her was for medical purposes only and wouldn’t have
any entitlement to go elsewhere.
GJ: So, your information is just for medical purposes?
R: Sure, except for what insurance is entitled to know.
(D173)
Another woman stated:
Table 1 Demographic characteristics of the
interview population
N %
Age
18–22 28 32.9
23–46 30 35.3
.46 27 31.8
Race
White non-Hispanic 43 50.6
African American 28 32.9
Asian 8 9.4
Hispanic 6 7.1
Income
,15 000 13 15.3
15000–24000 16 18.8
.24 000–40 000 20 23.5
.40 000–75 000 18 21.2
.75 000 16 18.8
Education
Some high school or high
school graduate
20 23.5
Some college 34 40.0
College graduate 30 35.3
Unknown 1 1.2
Women’s views on medical confidentiality 501
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I would think that what’s in my record, what’s in my chart
is in my chart and it doesn’t leave that office unless I give
permission for it to leave the office and be sent somewhere
else. No one else has to view it except for those people
who need to have access to that information for the
reasons that I stated before. (C164)
A small number of subjects (n=7) provided what we
labelled ‘‘negative definitions’’ in the sense that they
described only what could not be done with information,
such as:
It means that it’s private. It means that they may not share
this information with an insurance company or with
anyone if it’s confidential. (A221)
Distinctiveness of confidential medical information
Enquiry into patients’ definitions of confidentiality was
extended through questions such as ‘‘So, what part of the
information that you talk about with your doctor or nurse
is confidential?’’. Through these exchanges two distinct
concepts emerged of what constituted confidential informa-
tion. The first highlighted the content of information, naming
topics such as mental illness or sexual behaviour—for
example:
Well, I think that, I don’t have a problem with them
knowing the fact that I have seen a cardiologist and all
because it’s family history and stuff. But when it comes
down to private things that I’ve talked to them about, about
maybe my relationship with my husband or my relation-
ship with my children and stuff like that, I’m, depressed at
the time. I feel like those are things that unless I give you
permission to tell, I don’t really want you sharing those.
(D207)
Or, as one subject responded in answer to the question,
‘‘What kind of information really falls under that rubric of
confidentiality?’’:
Like if she [the physician] asks you what age is your
husband or how many people are you sleeping with. I
think that should stay between her … I think you shouldn’t
tell nobody about that. (A229)
Respondents giving these answers also often characterised
relationships with doctors as a context where they could
discuss
things that you can’t tell somebody else, you try to tell like
your doctor. (A135)
The second set of answers characterised all medical
information as confidential:
I’d say all of it, all of it. I understand that when I go into the
doctor’s office and a nurse may bring me in initially and
do a height and a weight and take my blood pressure, but
I could care less. That’s, you know, everybody has a height
and a weight and a blood pressure. So that’s, to me, non-
important stuff. But anything, anything that happens from
the point that that doctor enters the room that you’re sitting
in or waiting in to the point that the doctor leaves the room
and you’re done is supposed to be confidential. (D297)
Or,
Well actually all of it is confidential. I mean even weight
…. (C258)
The women holding this view explained that all medical
information was confidential because, by definition, what-
ever transpires between a doctor or clinic staff and patient is
confidential. Some explained that this was the case because
the meaning of information changes unpredictably in
different contexts. One young woman whose family paid
for her health insurance explained that even taking up
running as exercise could be sensitive information and in
need of confidentiality protection if her family disapproved of
the activity because of the dangers she might encounter
when running in her urban neighbourhood.
Handling confidential medical information
To further assess what labelling something confidential meant
to subjects, we also asked specific questions such as: ‘‘Does
this confidential information go into your medical record?’’
and ‘‘Would your doctor ever reveal this confidential
information?’’ These questions were analogous to the
preceding part of the interview when we posed similar
questions but without specifying or labelling the information
as confidential. Some women provided different answers to
these two sets of questions, stating that confidential
information was handled differently from other medical
information. For example, whereas almost all women had
indicated that medical information (not specified confiden-
tial) could and would be shared with others (even if some
respondents restricted this sharing to the clinic where it was
collected), nearly half of subjects responded that they
thought that confidential information was subject to special
controls that would strictly limit its circulation. In support of
this view some also stated that confidential medical
information would not go into the record and that the doctor
would never reveal it.
Disclosure deliberations
In response to open ended questions, women sometimes
related instances when they had deliberated whether to tell a
doctor about a health behaviour or health condition. We
coded these passages as revealing a concern with either
‘‘psychological privacy’’ or ‘‘informational privacy’’.
Sometimes respondents described deliberations over whether
to disclose information to doctors that incorporated elements
of both kinds of concern.
Psychological privacy is defined as the emotional experi-
ence of self-revelation and the right to determine ‘‘with
whom one will share thoughts and feelings or reveal intimate
information’’.42 The concern expressed in these passages was
with feelings caused by the demand to reveal information
typically unknown to others. The feelings included embar-
rassment, shame, and being judged. The commonest topics in
such passages included conditions associated with sexual
behaviour, followed by mental health and smoking. One
woman explained why she did not tell a new doctor that she
had had a gonorrhoeal infection that had been successfully
treated.
It paints a picture. They don’t ask how long ago. They just
say, did you have it? It puts something there in their mind
that would be negative about you and doesn’t necessarily
need to be, especially when it’s so old. (B258)
Informational privacy is defined the right to determine
‘‘what data about the self will be released to another
502 Jenkins, Merz, Sankar
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person’’.42 The concern expressed in these passages was with
the potential release of information to third parties, including
insurance companies, employers, and family members.
Mental illness was the topic most often of concern, except
with younger women for whom it was onset of sexual
activity. One woman described her thinking about disclosing
in a college application her history of depression, repeated
suicide attempts, and hospitalisations:
And obviously you know how they always ask you on
applications like college applications, they say like give us
your history. And I never checked the depression thing
obviously because I don’t want anybody to find out about
that … . (B169)
ANALYSIS
We examined patient views of medical confidentiality to
describe those views and assess whether they varied. The
interviews also were structured to examine the finding from
pilot interviews that some respondents thought of confiden-
tial information as categorically different from other medical
information, and the suggestion from previous research that
some patients used the term confidentiality differently from
standard legal or medical definitions. We interviewed women
to focus the study and because women experience a
particular confidentiality burden—reproductive health issues
and frequent responsibility for health care for other family
members.
We have been able to describe patient views of medical
confidentiality and to demonstrate that both definitions of
medical confidentiality and expectations of confidentiality
protections vary among patients. We found that views about
the proper handling of medical information not specified
confidential were similar across the subjects. For example,
subjects generally agreed that this information could and did
circulate. Views on whether information designated confiden-
tial was treated differently, if so and how, however, did vary
among subjects. Table 2 summarises the major findings
about the definition and treatment of medical information
designated confidential.
In support of findings from our pilot interviews, some
subjects did report considering confidentiality protections as
exceptional rather than routine and described them as
existing primarily to protect information deemed particularly
sensitive, such as mental illness. Our interviews also
demonstrated that some women defined confidentiality
substantially different from the standard legal or medical
definition. This was most evident among women who offered
definitions of medical confidentiality as private or secret
information held between two people, or ‘‘just between you
and the doctor’’. Furthermore, in at least some subjects, these
findings were linked together in that the definition of
confidentiality as private or secret information complemen-
ted the assumption that confidential medical information is
distinct from other medical information and is subject to
special treatment, such as not being entered in the patient’s
record.
DISCUSSION
Medical confidentiality provides an essential element of the
trust needed to build a successful doctor–patient relationship.
Research has shown that patients who feel that their
confidentiality is respected are more likely to seek treatment
and comply with recommendations.1–13 Our study, one of the
few to enquire directly of patients about their views of
medical confidentiality, suggests that while there is con-
siderable overlap between professional and legal definitions
and patient views, there are also important differences.
Some of these beliefs—for example, that confidential
information will not appear in the chart nor be released to
third parties—are most likely not what doctors intend to
communicate with the statement that something will be kept
confidential, nor the meaning of confidentiality embodied in
the HIPAA privacy rule. Furthermore, anecdotal reports
suggest that the recommended methods under HIPAA for
explaining confidentiality policies to patients are unlikely to
address or even detect such assumptions.
Forging a trusting relationship with such patients presents
a conundrum. Explaining the current limits of confidentiality
(as for example required by HIPAA) could trigger a retreat
into silence or dissimulation about certain conditions. At the
same time, ignoring the misunderstanding could result in an
even greater rift in the event that the patient learns elsewhere
what confidentiality actually means in most healthcare
settings. The truth is that medical confidentiality simply fails
the needs or expectations of some patients. To pretend
otherwise and allow these patients to continue believing their
information is secret when it is not is shortsighted and
paternalistic. A more open approach to this issue might
engender the continued public debate needed to advance
beyond the current impasse.
A more productive starting point is perhaps to recognise
that patients have their own models of medical confidenti-
ality, to ask what they are, and if necessary to explain how
and for what reasons actual practice differs. For some
patients, this gesture alone may help. A 1999 study found
that people at risk for HIV were more likely to agree to testing
that could result in contact tracing if the public health
advantages of contact tracing were explained to them.7 Many
situations, however, will call for more than an explanation,
and additional research into what fosters the need for secrecy
among some patients can help.
To respond to patients who desire that their information
remain secret when it likely cannot, we need to know more
about these concerns. What feeds the emotional dread of self-
revelation in medical settings? Is it a fear of social stigma
resulting from beliefs about the cause or consequences of a
condition, or assumptions about what can, or what should,
be said to doctors? What is the role of worries about loss of
life insurance or diminished employability? Research needs
to assess how well current medical confidentiality policy
addresses all of the identified concerns.
Reinvigorating medical confidentiality and creating an
atmosphere of trust between doctor and patient in which all
Table 2 Features of patients’ views of medical
confidentiality
Definitions of medical confidentiality
Information stays between two people
Information restricted to medical care or insurance
Negative definition
What information is confidential
Specific topics such as mental illness or sexually transmitted diseases
Everything in the medical record
Handling confidential information
Remembered by doctor, not recorded
Recorded but not where others might easily read it
Entered in medical record
Release to third party of confidential information to third party
Would not be released
Could be released under exceptional circumstances
Routinely released for medical care or reimbursement
Concern when deliberating confidential information disclosure
Disclosed selectively. Concerned with emotional consequence of
self-revelation
Disclose all needed for treatment. Some concern with institutional
consequences, such as insurance eligibility
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patients feel secure enough to easily communicate their
concerns is an ongoing and challenging project. Continued
research and policy reform efforts are required. This research
suggests that one practical step is to recognise that patients
have their own beliefs about the function and procedures of
medical confidentiality and to begin to enquire about them.
Limits
Our analysis revealed that views of medical confidentiality
differed among subjects; some reported views were demon-
strably different from the conventional definition of medical
confidentiality. Additional research is needed to determine
the extent to which views expressed by women in our sample
are also present in the general population. Because we relied
on volunteers, our sample might have consisted of women
with heightened concerns about confidentiality that could
have biased the responses.
Furthermore, the research examined only views held by
women. We made this choice to narrow the range of potential
findings and because of the distinctive considerations of
confidentiality that accompany women’s health, such as
reproductive issues and their frequent responsibility for
seeking health care for members of their family. As many
of the subjects’ comments were related to reproductive
health, primarily pregnancy, interviews with men will likely
produce different results, although the basic definitions and
beliefs might remain the same. Also, the interviews in the
present study were conducted in one region of the USA
among a predominantly urban population that might limit
the populations to which these findings can be generalised.
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10 Charbonneau A, Maheux B, Béland F. Do people with HIV/AIDS disclose
their HIV-positivity to dentists? AIDS Care 1999;11:61–70.
11 Mansfield SJ, Singh S. The general practitioner and human immunodeficiency
virus infection: an insight into patients’ attitudes. J R Coll Gen Pract
1989;39:104–5.
12 Miller PJ, Torzillo PJ. Private business: the uptake of confidential HIV testing in
remote aboriginal communities on the Anangu Pitjantjatjara Lands.
Aust N Z J Public Health 1998;22:700–3.
13 Robinson P, Zakrzewska JM, Maini M, et al. Dental visiting behaviour and
experiences of men with HIV. BDJ 1994;176:175–9.
14 Standards for privacy of individually identifiable health information. Final rule.
Federal Register 2002;67:53181–273.
15 Standards for privacy of individually identifiable health information. Federal
Register 2000;65:82511–60.
16 Claiborn C. The client’s perspective: ethical judgments and perceptions of
therapist practices. Prof Psychol Res Pr 1994;25:268–74.
17 Hurley JC, Underwood MK. Children’s understanding of their research rights
before and after debriefing: informed assent, confidentiality, and stopping
participation. Child Dev 2002;73:132.
18 Lindenthal JJ, Thomas CS. Psychiatrists, the public, and confidentiality. J Nerv
Ment Dis 1982;170:319–23.
19 Messenger CB, McGuire JM. The child’s conception of confidentiality in the
therapeutic relationship. Psychotherapy 1981;18:123–30.
20 McGuire J, Toal P, Blau B. The adult patient’s conception of confidentiality in
the therapeutic relationship. Prof Psychol 1985;16:375–84.
21 Rosen CE. Why clients relinquish their rights to privacy under sign-away
pressures. Prof Psychol 1977;8:17–24.
22 Kinzie JD, Holmes JL, Arent J. Patients’ release of medical records:
involuntary, uninformed consent? Hosp Community Psychiatry
1985;36:843–7.
23 Lorge RE. How informed is patients’ consent to release of medical information
to insurance companies? BMJ 1989;298:1495–6.
24 Day S. Letters—medical privacy rules definitely a burden. The San Diego
Union-Tribune 25 April 2003, Sect B–9.
25 Gellman R. The health privacy rule after eight months. Law and Bioethics
Report, Institute for Bioethics, Health Policy and Law, University of Louisville
School of Medicine 2003–2004;3:3.
26 Derus M. New Privacy Paperwork Confuses.Milwaukee Journal Sentinel May
12 2003, Sect.1-D.
27 Sorkin MD. Privacy law has unforseen implications. St. Louis Post-Dispatch 29
June 2003, Sect A-12.
28 Austin M. Tough new patient privacy rules go into effect April 14. The Denver
Post 10 February 2003, Sect C-01.
29 Ornstein S, Bearden A. Patient perspectives on computer-based medical
records. J Fam Pract 1994;38:606–10.
30 Bendtsen P, Timpka T. Acceptability of computerized self report of alcohol
habits: a patient perspective. Alcohol 1999;34:575–80.
31 Jones C. The utilitarian argument for medical confidentiality: a pilot study of
patients’ views. J Med Ethics 2003;29:348–55.
32 Robling M, Hood K, Houston H, et al. Public attitudes toward the use of
primary care patient record data in medical research without consent: a
qualitative study. J Med Ethics 2004;30:104–6.
33 Sankar P, Moran S, Merz J, et al. Patient perspectives of medical
confidentiality. A review of the literature. J Gen Intern Med 2003;8:659–69.
34 Cheng TL, Savageau JA, Satter AL, et al. Confidentiality in health care. a
survey of knowledge, perceptions, and attitudes among high school students.
JAMA 1993;269:1404–7.
35 Samet J, Winter M, Grant L, et al. Factors associated with HIV testing among
sexually active adolescents: a Massachusetts survey. Pediatrics
1997;100:371–7.
36 Mechanic D, Meyer S. Concepts of trust among patients with serious illness.
Soc Sci Med 2000;51:657–68.
37 Apel S. Privacy in genetic testing: why women are different. South Calif
Interdiscip Law J 2001;11:1–26.
38 Marsh A. Testing pregnant women and newborns for HIV: legal and ethical
responses to public health efforts to prevent pediatric AIDS. Yale J Law Fem
2001;13:195–263.
39 Rodriguez M, Sheldon W, Rao N. Abused patient’s attitudes about mandatory
reporting of intimate partner abuse injuries to police. Women Health
2002;35:135–47.
40 Peters N, Rose A, Armstrong K. The association between race and attitudes
about predictive genetic testing. Cancer Epidemiol Biomarkers Prev
2004;13:361–5.
41 PCPC Philadelphia City Planning Commission. www.philaplanning.org/
data/datamaps.html (accessed 22 November 2004).
42 Parrott R, Burgoon JK, Burgoon M, et al. Privacy between physicians and
patients: more than a matter of confidentiality. Soc Sci Med 1989;29:1381–5.
504 Jenkins, Merz, Sankar
www.jmedethics.com
 on 12 March 2007 jme.bmj.comDownloaded from 
